Susquehanna International Group
RYTM icon

Susquehanna International Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Susquehanna International Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Sell
13,500
-4,500
-25% -$438K ﹤0.01% 7469
2025
Q4 		$1.93M Sell
18,000
-91,700
-84% -$9.73M ﹤0.01% 5741
2025
Q3 		$11.1M Sell
109,700
-23,800
-18% -$2.21M ﹤0.01% 2909
2025
Q2 		$8.44M Buy
133,500
+111,200
+499% +$6.81M ﹤0.01% 3087
2025
Q1 		$1.18M Buy
22,300
+6,300
+39% +$350K ﹤0.01% 6836
2024
Q4 		$896K Sell
16,000
-21,600
-57% -$1.19M ﹤0.01% 7244
2024
Q3 		$1.97M Buy
37,600
+10,900
+41% +$522K ﹤0.01% 5297
2024
Q2 		$1.1M Sell
26,700
-16,800
-39% -$671K ﹤0.01% 6362
2024
Q1 		$1.88M Buy
43,500
+16,900
+64% +$740K ﹤0.01% 5482
2023
Q4 		$1.22M Buy
26,600
+17,700
+199% +$558K ﹤0.01% 6489
2023
Q3 		$204K Buy
+8,900
New +$199K ﹤0.01% 10184
2023
Q2 		– Sell
-48,500
Closed -$865K – 12997
2023
Q1 		$865K Buy
48,500
+8,800
+22% +$221K ﹤0.01% 7199
2022
Q4 		$1.16M Sell
39,700
-62,400
-61% -$1.6M ﹤0.01% 5854
2022
Q3 		$2.5M Buy
+102,100
New +$1.9M ﹤0.01% 4460
2022
Q2 		– Sell
-15,700
Closed -$181K – 13813
2022
Q1 		$181K Buy
+15,700
New +$138K ﹤0.01% 11359
2021
Q3 		– Sell
-12,700
Closed -$249K – 13454
2021
Q2 		$249K Sell
12,700
-19,500
-61% -$405K ﹤0.01% 11153
2021
Q1 		$685K Sell
32,200
-115,200
-78% -$3.34M ﹤0.01% 8724
2020
Q4 		$4.38M Buy
147,400
+90,700
+160% +$2.31M ﹤0.01% 3635
2020
Q3 		$1.23M Buy
+56,700
New +$1.3M ﹤0.01% 5622

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Susquehanna International Group's RYTM Position: Q1 2026 in Review

Susquehanna International Group increased its Rhythm Pharmaceuticals (RYTM) stake by 1,140% in Q1 2026, buying an estimated $4.54M and bringing the position to 50,784 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #4463.

Susquehanna International Group first reported a position in RYTM in Q2 2019 and has held it in 27 quarters since. The position peaked at $20.2M in Q4 2022. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Susquehanna International Group held 50,784 shares of Rhythm Pharmaceuticals worth $4.42M as of Q1 2026.
  • Susquehanna International Group bought 46,687 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $4.54M.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4463 holding.
  • Susquehanna International Group first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Rhythm Pharmaceuticals position peaked at $20.2M in Q4 2022.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.